C231H185Cl4N45O18S2 — CID 160764505
N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]pyridine-3-carboxamide;N-[4-[6-(adamantane-1-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,4-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,6-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2-phenylcyclopropanecarbonyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;bis(N-[4-[6-(thiophene-3-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide) (PubChem CID 160764505) has the molecular formula C231H185Cl4N45O18S2 and a molecular weight of 4085.26 g/mol. Its IUPAC name is N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]pyridine-3-carboxamide;N-[4-[6-(adamantane-1-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,4-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,6-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2-phenylcyclopropanecarbonyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;bis(N-[4-[6-(thiophene-3-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide).
| Compound Name | N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]pyridine-3-carboxamide;N-[4-[6-(adamantane-1-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,4-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,6-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2-phenylcyclopropanecarbonyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;bis(N-[4-[6-(thiophene-3-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide) |
|---|---|
| PubChem CID | 160764505 |
| Molecular Formula | C231H185Cl4N45O18S2 |
| Molecular Weight | 4085.26 g/mol |
| Exact Mass | 4080.31 |
| IUPAC Name | N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]pyridine-3-carboxamide;N-[4-[6-(adamantane-1-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,4-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,6-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2-phenylcyclopropanecarbonyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;bis(N-[4-[6-(thiophene-3-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide) |
| SMILES | CC(=O)Nc1ccc2nc(-c3ccc(NC(=O)c4cccnc4)cc3)[nH]c2c1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C45CC6CC(CC(C6)C4)C5)cc3[nH]2)cc1)c1cccnc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CC4c4ccccc4)cc3[nH]2)cc1)c1cccnc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CCCC4)cc3[nH]2)cc1)c1cccnc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CCCCC4)cc3[nH]2)cc1)c1cccnc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)c4c(Cl)cccc4Cl)cc3[nH]2)cc1)c1cccnc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)c4ccc(Cl)cc4Cl)cc3[nH]2)cc1)c1cccnc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)c4ccsc4)cc3[nH]2)cc1)c1cccnc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)c4ccsc4)cc3[nH]2)cc1)c1cccnc1 |
| InChI | InChI=1S/C30H29N5O2.C29H23N5O2.2C26H17Cl2N5O2.C26H25N5O2.C25H23N5O2.2C24H17N5O2S.C21H17N5O2/c36-28(22-2-1-9-31-17-22)32-23-5-3-21(4-6-23)27-34-25-8-7-24(13-26(25)35-27)33-29(37)30-14-18-10-19(15-30)12-20(11-18)16-30;35-28(20-7-4-14-30-17-20)31-21-10-8-19(9-11-21)27-33-25-13-12-22(15-26(25)34-27)32-29(36)24-16-23(24)18-5-2-1-3-6-18;27-19-4-1-5-20(28)23(19)26(35)31-18-10-11-21-22(13-18)33-24(32-21)15-6-8-17(9-7-15)30-25(34)16-3-2-12-29-14-16;27-17-5-9-20(21(28)12-17)26(35)31-19-8-10-22-23(13-19)33-24(32-22)15-3-6-18(7-4-15)30-25(34)16-2-1-11-29-14-16;32-25(18-5-2-1-3-6-18)29-21-12-13-22-23(15-21)31-24(30-22)17-8-10-20(11-9-17)28-26(33)19-7-4-14-27-16-19;31-24(17-4-1-2-5-17)28-20-11-12-21-22(14-20)30-23(29-21)16-7-9-19(10-8-16)27-25(32)18-6-3-13-26-15-18;2*30-23(16-2-1-10-25-13-16)26-18-5-3-15(4-6-18)22-28-20-8-7-19(12-21(20)29-22)27-24(31)17-9-11-32-14-17;1-13(27)23-17-8-9-18-19(11-17)26-20(25-18)14-4-6-16(7-5-14)24-21(28)15-3-2-10-22-12-15/h1-9,13,17-20H,10-12,14-16H2,(H,32,36)(H,33,37)(H,34,35);1-15,17,23-24H,16H2,(H,31,35)(H,32,36)(H,33,34);2*1-14H,(H,30,34)(H,31,35)(H,32,33);4,7-16,18H,1-3,5-6H2,(H,28,33)(H,29,32)(H,30,31);3,6-15,17H,1-2,4-5H2,(H,27,32)(H,28,31)(H,29,30);2*1-14H,(H,26,30)(H,27,31)(H,28,29);2-12H,1H3,(H,23,27)(H,24,28)(H,25,26) |
| InChIKey | RYMTXPOYIMBXIE-UHFFFAOYSA-N |
| XLogP | 49.14 |
| TPSA | 897.93 Ų |
| H-Bond Donors | 27 |
| H-Bond Acceptors | 38 |
| Rotatable Bonds | 45 |
| Heavy Atoms | 300 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 4085.26 |
| LogP ≤ 5 | 49.14 |
| H-Bond Donors ≤ 5 | 27 |
| H-Bond Acceptors ≤ 10 | 38 |